Following cerebral ischemia, treatment with different compounds, such as melatonin, methylene blue, and rapamycin, promotes the inhibition of ROS generation and NLRP3 inflammasome activation by enhancing the mitophagy process [237,238,239] (Figure 2). This evidence concerns the gene NLRP3 and brain ischemia.